Navigation Links
Failing Heart Failure Patients

Australian teaching hospitals may be putting heart failure patients at further risk through a reluctance to prescribe them life-saving cardiovascular drugs.//

A recent study, published in the latest edition of the Medical Journal of Australia, evaluated the use of cardiovascular medications in patients with and without heart failure after a myocardial infarction (MI), otherwise known as a heart attack.

“Heart failure is a common and potentially lethal complication of MI, conferring a four-to-fivefold increase in mortality,” says Professor Henry Krum, co-author of the study and head of the NHMRC Centre of Clinical Research Excellence in Therapeutics at Monash University in Melbourne.

He says cardiovascular medication reduces the risk of disease and death in affected patients, but it is not known whether evidence-based prescribing occurs in Australian teaching hospitals.

Of the 479 patients admitted for MI who participated in the study, 116 had heart failure at some point during their hospitalisation.

But the MI patients were significantly less likely to be prescribed some types of cardiovascular medication than patients without heart failure.

Prof Krum says recent analyses have confirmed that some MI patients do derive substantial benefit from proven heart failure therapies, and their use should therefore be encouraged.

However he noted that the low prescribing rates may be explained by concerns over low blood pressure and greater clinical instability in patients with heart failure.

“In managing patients with heart failure, … the net benefit of multiple agents has to be weighed against the risks and the possibility of adverse events and drug interactions,” says Prof Krum.

“Patients with heart failure receive fewer life-saving drug therapies compared with those who do not have heart failure. These deficiencies in prescribing may lead to substantial increases in [cardiovascular] events in these patients.

“Given the absolute benefit of drug therapy in patients with heart failure after MI, our findings suggests the potential for suboptimal prescribing [exists] in Australian teaching hospital pracice.”
'"/>




Related medicine news :

1. College Student Commits Suicide After Failing In HSC Exams
2. "Serious Failings" Led To Spread Of Lethal Hospital Bug
3. New Device May Help Heal A Failing Heart
4. Special Exams to Help Failing Medical Students
5. Is There Any Clinical Benefit to Staying on a Failing Regimen?
6. One in Three Heart Attack Patients Have No Chest Pains
7. Epileptic Seizures Can Be Due to Heart Problem
8. Bypass Heart Surgery Performed Without General Anesthesia
9. New CPR Guidelines issued by Heart Association
10. White Cells Count Can Predict Heart Attack Death Risk
11. Vitamins-The answer to Heart Disease?
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/17/2017)... Seattle, WA (PRWEB) , ... February 17, 2017 ... ... health management organizations, has been named a finalist in the 8th Annual DecisionHealth ... impacting America's healthcare delivery system. Qualis Health’s work is recognized across multiple award ...
(Date:2/17/2017)... (PRWEB) , ... February 17, 2017 , ... ... cycle management services, announced today that Karen Pilley has been promoted to Chief ... critical in today’s shifting healthcare paradigm – a shift that demands the transition ...
(Date:2/17/2017)... ... February 17, 2017 , ... Cancer diagnostics workflow ... Tri-Conference February 20 – 22 in San Francisco. As part of the Tri-Conference ... molecular pathology workflow solution, as well as its new precision medicine platform, “Crosswalk ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... financial planning assistance to families and business owners in and around the Hampton ... drive to help prevent all forms of domestic violence. , There are multiple ...
(Date:2/16/2017)... ... February 17, 2017 , ... For ... long after their final treatments. Physician researchers at The Marcus Institute of ... mind-body therapy, for efficacy in reducing symptoms of traumatic stress in cancer patients ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... Arvinas LLC, a private biotechnology company creating ... today announced the presentation of new preclinical data on ... session at the American Society of Clinical Oncology 2017 ... FL. "The new data ... potential of PROTACs to drive durable and robust responses ...
(Date:2/17/2017)... Research and Markets has announced the addition of ... their offering. ... separate comprehensive analytics for the US, Canada , ... , Latin America , and Rest of World. ... Also, a six-year historic analysis is provided for these markets. Market data ...
(Date:2/17/2017)... 17, 2017  Featuring new and ... the  2017 HIMSS Conference & Exhibition (HIMSS17 ),  Royal ... global leader in health technology,  will ... population health management, acute healthcare informatics ... a highly secure, cloud-based ecosystem. Visitors ...
Breaking Medicine Technology: